Literature DB >> 16241965

Lepirudin: is the approved dosing schedule too high?

M Hacquard, E de Maistre, T Lecompte.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16241965     DOI： 10.1111/j.1538-7836.2005.01620.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Thrombosis during lepirudin therapy: a case report.

Authors:  F Wallet; F Bayle; V Leray; J C Richard; G Bourdin; C Guérin
Journal:  Intensive Care Med       Date:  2008-11-26       Impact factor: 17.440

2.  On the dosing of lepirudin.

Authors:  Lorenzo Alberio; Bernhard Lämmle
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

Review 3.  Direct thrombin inhibitors: pharmacology and application in intensive care medicine.

Authors:  Eva Schaden; Sibylle A Kozek-Langenecker
Journal:  Intensive Care Med       Date:  2010-04-28       Impact factor: 17.440

4.  Heparin-dependent platelet factor 4 antibodies and the impact of renal function on clinical outcomes: a retrospective study in hospitalized patients.

Authors:  S L Perry; N L Whitlatch; T L Ortel
Journal:  J Thromb Thrombolysis       Date:  2008-10-07       Impact factor: 2.300
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.